Development and application of virus-specific T cells
The differences between biological and chronological age, with their implications on AML treatment
Do Philadelphia chromosome-positive ALL patients need a stem cell transplant?
Factors to consider when choosing treatment for relapsed multiple myeloma patients
Re-analysis of RESONATE-2 trial of ibrutinib vs chlorambucil in CLL